Sell signal in confirmation, decline slows down
Recursion Pharmaceuticals steadies (+0.5%): the decline loses steam
Sell signal in confirmation, decline slows down
Our view last week
Recursion Pharmaceuticals stock plunges 17.3% this week as a fresh Sell signal fires: the caution flagged last week has now played out, with sellers firmly back in control and only 16.7% of the day's volume coming from buyers. Price is back at the edge of the double bottom in the 2.9 area, on a highly volatile name. This week's technical analysis has signal strength at 98 out of 100: "downtrend making lower lows, pace holding". Trading not recommended.
This week's summary
After last week's plunge, Recursion Pharmaceuticals catches its breath: the stock closes +0.5% and forms a double bottom in the 2.9 area, with a 6% rebound off the lows. In this week's Recursion technical analysis, signal strength drops from 98 to 34 out of 100, a decline losing steam; but sellers still hold the upper hand, with only 23.5% of volume on the buy side and money flow still negative.
Sell signal in observation
·2nd week from start
·US stocks
·T2
·📅 Earnings · Aug 11
★ See Gold version →
IQS Phase
77
in tension
Signal Strength
34
decline losing steam
Sizing
REDUCED
Ranking
#82 / 141
US stocks sell signals
Trade P&L %
-0.51%
from signal to today
Rank position
ranks 82nd among the 141 sell signals for US stocks in our ranking, with a signal strength of 34 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
RXRX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content